Cargando…
Is tau in the absence of amyloid on the Alzheimer’s continuum?: A study of discordant PET positivity
The amyloid cascade model of Alzheimer’s disease posits the primacy of amyloid beta deposition preceding tau-mediated neurofibrillary tangle formation. The amyloid-tau-neurodegeneration biomarker-only diagnostic framework similarly requires the presence of amyloid beta for a diagnosis on the Alzheim...
Autores principales: | Weigand, Alexandra J, Bangen, Katherine J, Thomas, Kelsey R, Delano-Wood, Lisa, Gilbert, Paul E, Brickman, Adam M, Bondi, Mark W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001143/ https://www.ncbi.nlm.nih.gov/pubmed/32051933 http://dx.doi.org/10.1093/braincomms/fcz046 |
Ejemplares similares
-
Comprehensive characterization of elevated tau PET signal in the absence of amyloid-beta
por: Weigand, Alexandra J, et al.
Publicado: (2022) -
Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam‐era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD‐ADNI) study
por: Clark, Alexandra L., et al.
Publicado: (2021) -
White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia
por: Edwards, Lauren, et al.
Publicado: (2023) -
Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
por: Thomas, Kelsey R., et al.
Publicado: (2021) -
Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint
por: Thomas, Kelsey R., et al.
Publicado: (2022)